Carmel Devlin

Statistics

Publications

Citations

426

H-Index

Active since

2010

Affiliations

Pfizer (United States)(Current)

Pfizer (Germany)

Carmel Devlin is an author at Pfizer (United States) specializing in pneumococcal conjugate vaccines, vaccination, and pneumococcal conjugate vaccination.

Publications per year

2010–2013

Publications

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults

Lisa A. Jackson, Alejandra Gurtman, Martin van Cleeff et al. · Vaccine · 2013 · 235 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany

Dorothee Kieninger, Kathrin Kueper, Katrin Steul et al. · Vaccine · 2010 · 168 citations

Veterinary Medicine, Immunology, Pediatrics +17

13-valent Pneumococcal Conjugate Vaccine in Older Children and Adolescents Either Previously Immunized With or Naïve to 7-valent Pneumococcal Conjugate Vaccine

Robert W. Frenck, Allison Thompson, Shelly Senders et al. · The Pediatric Infectious Disease Journal · 2013 · 23 citations

Veterinary Medicine, Immunology, Pediatrics +17

1–3 of 3